Altria Group Inc vs Xylem, Inc. — how do they compare? Altria Group Inc trades at $71.68 (market cap $119.25B), while Xylem, Inc. trades at $102.71 (market cap $23.81B). The key difference: Altria Group Inc is far larger — about 5× Xylem, Inc.'s market cap, and Altria Group Inc pays the higher dividend (6.22%). Which is the better fit depends on your goals — on Pluang, investors hold Altria Group Inc for 154 Days and Xylem, Inc. for 50 Days on average.
| MO | XYL | |
|---|---|---|
Market Cap | $119.25B | $23.81B |
Volume | 11,178,169 | 2,234,713 |
Sector | Consumer Staples | Industrials |
52-Week High | $74.92 | $152.95 |
52-Week Low | $54.72 | $100.92 |
Typical Hold Time | 154 Days | 50 Days |
Enterprise Value | $141.46B | $25.59B |
Dividend Yield | 6.22% | 1.69% |
Signals from Pluang's Aura AI — not financial advice
Altria Group (MO) trades at $71.43, up 2.95% with a bullish technical signal and strong cash flow generation. The stock shows mixed earnings performance with two misses and one beat in recent quarters, while maintaining a 39% net income margin and $9.3B operating cash flow. Recent news highlights the company's 6.6% dividend yield and 60 consecutive annual increases, though some analysts express concerns about negative equity and regulatory challenges.
MO presents a compelling income opportunity with its high dividend yield and consistent payout history, but faces headwinds from declining cigarette volumes and regulatory uncertainty. The stock trades below analyst consensus target of $69.71, offering potential upside if the company successfully navigates its smoke-free transition. Key risks include negative shareholder equity and margin pressure from shifting consumer preferences.
XYL trades at $101.99, up 0.16% on the day, with a bearish technical signal from moving averages despite neutral oscillators. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected on October 27, 2026. Revenue grew to $9.04B in 2025, and net income margin improved to 10.59%. Recent acquisitions of Cornell Pump and Roper Pump aim to strengthen its industrial water solutions presence.
The outlook is supported by solid fundamentals and a consensus price target of $149.13, implying significant upside. Risks include China market weakness and higher debt from recent note offerings. Analyst sentiment is mixed with 47.5% buy ratings, but institutional interest remains strong, as seen in Bank of America's new position in Q2 2026.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →